Insights into the efficacy of golimumab plus methotrexate in patients with active rheumatoid arthritis who discontinued prior anti-tumour necrosis factor therapy: Post-hoc analyses from the GO-AFTER study

Josef S. Smolen, Jonathan Kay, Eric L. Matteson, Robert Landewé, Elizabeth C. Hsia, Stephen Xu, Yiying Zhou, Mittie K. Doyle

Research output: Contribution to journalArticle

18 Scopus citations


Objective: Evaluate golimumab in patients with active rheumatoid arthritis (RA) and previous tumour necrosis factor-α (TNF) inhibitor use.

Original languageEnglish (US)
Pages (from-to)1811-1818
Number of pages8
JournalAnnals of the rheumatic diseases
Issue number10
StatePublished - Oct 1 2014


ASJC Scopus subject areas

  • Immunology and Allergy
  • Rheumatology
  • Immunology
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this